By Professor Andrew Lloyd

Journal articles

Lloyd AR, 2004, 'To exercise or not to exercise in chronic fatigue syndrome?', Medical Journal of Australia, 181, pp. 578 - 580, http://dx.doi.org/10.5694/j.1326-5377.2004.tb06459.x

Lloyd AR, 2004, 'To exercise or not to exercise in chronic fatigue syndrome? No longer a question', Medical Journal of Australia, 180, pp. 437 - 438

Lloyd AR, 2004, 'To exercise or not to exercise in chronic fatigue syndrome? Reply', Medical Journal of Australia, 181, pp. 579 - 580

Freeman AJ; Ffrench RA; Post JJ; Harvey CE; Gilmour S; White PA; Marinos G; Rawlinson WD; Van Beek IA; Lloyd AR, 2004, 'Virus-specific cellular immunity is prevalent among hepatitis C-resistant injecting drug users', Journal of Infectious Diseases, 190, pp. 1093 - 1097

Grimm MC; Newman R; Hassim Z; Cuan N; Connor SJ; Le Y; Wang JM; Oppenheim JJ; Lloyd AR, 2003, 'Cutting Edge: Vasoactive Intestinal Peptide Acts as a Potent Suppressor of Inflammation In Vivo by Trans-Deactivating Chemokine Receptors', Journal of Immunology, 171, pp. 4990 - 4994, http://dx.doi.org/10.4049/jimmunol.171.10.4990

Vollmer-Conna U; Davenport T; Hickie I; Wakefield D; Lloyd A, 2003, 'Sick, sleepy and sad', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 55, pp. 95 - 95, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000186983200420&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Smith AJ; Vollmer-Conna U; Bennett B; Wakefield D; Hickie IB; Lloyd AR, 2003, 'The effect of examination stress on the development of a primary immune response', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 55, pp. 28 - 28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000186983200109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Smith AJ; Bennett B; Vollmer-Conna U; Wakefield D; Hickie IB; Lloyd AR, 2003, 'The relationship between distress and the development of a primary immune response', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 55, pp. 92 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000186983200402&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Harvey CE; Post JJ; Palladinetti P; Freeman AJ; Ffrench R; Kumar RK; Marinos G; Lloyd AR, 2003, 'Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation', Journal of Leukocyte Biology, 74, pp. 360 - 369

Reeves W; Lloyd AR; Vernon S; Klimas N; Jason L; Bleijenberg G; Evengard B; White P; Nisenbaum R; Unger E, 2003, 'Identification of ambiguities in the 1994 chronic fatigue syndromeresearch case definition and recommendations for resolution', BMC Health Services Research, 3, pp. 1 - 9, http://dx.doi.org/10.1186/1472-6963-3-1

Robertson PW; Beynon S; Whybin R; Brennan CM; Vollmer-Conna US; Hickie IB; Lloyd AR, 2003, 'Measurement of EBV-1gG and t-VCA avidity aids the early and reliable diagnosis of primary EBV infection', Journal of Medical Virology, 70, pp. 617 - 623

Senanayake SN; Kelly JJ; Lloyd AR; Waliuzzaman Z; Goldstein D; Rawlinson WD, 2003, 'Multicentric Castleman's Disease Treated with Antivirals and Immunosuppressants', Journal of Medical Virology, 71, pp. 399 - 403

Xue ML; Wakefield D; Willcox MD; Lloyd AR; Di Girolamo N; Cole NA; Thakur A, 2003, 'Regulation of MMPs and TIMPs by IL-1â during Corneal Ulceration and Infection', Investigative Ophthalmology and Visual Science, 44, pp. 2020 - 2025

Xue ML; Thakur A; Willcox MD; Zhu H; Lloyd AR; Wakefield D, 2003, 'Role and regulation of CXC-chemokines in acute experimental keratitis', Experimental Eye Research, 76, pp. 221 - 231

Freeman A; Pan Y; Harvey CE; Post JJ; Law MG; White PA; Rawlinson WD; Lloyd AR; Marinos G; Ffrench R, 2003, 'The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection', Journal of Hepatology, 38, pp. 349 - 356

Grimm M; Newman R; Hassim Z; Cuan N; Connor SJ; Wang J; Oppenheim JJ; Lloyd AR, 2003, 'Vasoactive intestinal peptide acts as a potent suppressor of inflammation in vivo by trans-deactivating chemokine receptors', Journal of Immunology, 171, pp. 4990 - 4994

Dore GJ; Freeman AJ; Kaldor JM; Post JJ; Harvey CE; Ffrench RA; Lloyd AR; Mehta SH; Cox AL; Strathdee SA; Vlahov D; Thomas DL, 2002, 'Immunity against hepatitis C virus infection [2] (multiple letters)', Lancet, 360, pp. 1019 - 1020, http://dx.doi.org/10.1016/s0140-6736(02)11102-0

Loblay R; Toulkidis V; Hickie I; Lloyd A; Phillips B; Phoon WO; Rowe K; Steven I; Wakefield D; Watson D; Stewart G; Bertouch J; Cistulli P; Darveniza P; Ellis C; Gatenby P; Gillis D; Hickie I; Lloyd A; Phillips B; Phoon WO; Rowe K; Steven I; Wakefield D; Watson DO; Toulkidis V, 2002, 'Clinical practice guidelines - 2002', MEDICAL JOURNAL OF AUSTRALIA, 176, pp. S21 - S55, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000175489800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dore GJ; Freeman A; Kaldor JM, 2002, '. Immunity against hepatitis C virus infection', Lancet, 360, pp. 1019 - 1020

Post JJ; Konecny P; Lloyd AR; Jones PD, 2002, 'Acute Q fever and brachial neuritis: Case report and literature review', Infection, 30, pp. 400 - 402

Bertouch J; Cistulli P; Darveniza P; Ellis C; Gatenby P; Gillis D; Hickie IB; Phillips I; Phoon W; Rowe K; Steven I; Wakefield D; Watson D, 2002, 'Chronic Fatigue Syndrome Clinical Practice Guidelines', Medical Journal of Australia, 176

Kumar RK; Thomas PS; Seetoo DQ; Herbert C; McKenzie AN; Foster PS; Lloyd AR, 2002, 'Eotaxin expression by epithelial cells and plasma cells in chronic asthma', Lab Invest, 82, pp. 495 - 504, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11950906

Post JJ; Freeman A; Harvey CE; Ffrench R; Lloyd AROLA, 2002, 'Immunity against hepatitis C virus infection', Lancet, 360, pp. 1020 - 1020

White PA; Freeman A; Marinos G; Ffrench R; Rawlinson WD; Pan Y; Lloyd AR, 2002, 'Quantification of Hepatitis C Virus in Human Liver and Serum Samples by Using LightCycler Reverse Transcriptase PCR', Journal of Clinical Microbiology, 40, pp. 4346 - 4348, http://dx.doi.org/10.1128/JCM.40.11.4346-4348.2002

Thakur A; Xue ML; Stapleton FJ; Lloyd AR; Wakefield D; Willcox MD, 2002, 'The balance of pro- and anti-inflammatory cytokines correlates with the outcome of acute experimental Pseudomonas keratitis', Infection and Immunity, 70, pp. 2187 - 2197

Smith AJ; Bennett B; Vollmer-Conna U; Wakefield D; Hickie IB; Lloyd AR, 2001, 'The effect of distress on the development of a primary immune response', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 53, pp. 175 - 175, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000202876001305&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hickie IB; Bansal AS; Kirk KM; Lloyd AR; Martin NG, 2001, 'A twin study of the etiology of prolonged fatigue and immune activation', Twin Research, pp. 94 - 102

Post JJ; Dolan K; Whybin R; Carter I; Haber P; Lloyd AR, 2001, 'Acute hepatitis C virus infection in an Australian prison inmate: tattooing as a possible transmission route', Medical Journal of Australia, 174, pp. 183 - 184

Connor SJ; Cardillo R; Cuan N; Amansec S; Conway P; Lloyd AR; Grimm MC, 2001, 'Amelioration of TNBS colitis in mice using preblotics', Gastroenterology, 120, pp. A82 - A82, http://dx.doi.org/10.1016/s0016-5085(08)80404-0

Freeman A; Dore GJ; Law MG; Thorpe M; Von Overbeck J; Lloyd AR; Marinos G; Kaldor JM, 2001, 'Estimating progression to cirrhosis in chronic hepatitis C virus infection.', Hepatology, pp. 809 - 816

Thakur A; Xue ML; Wang W; Lloyd AR; Wakefield D; Willcox MD, 2001, 'Expression of macrophage migration inhibitory factor during Pseudomonas keratitis', Clinical and Experimental Ophthalmology, pp. 179 - 182

Freeman A; Marinos G; Ffrench R; Lloyd AR, 2001, 'Immunopathogenesis of hepatitis C virus infection', Immunology and Cell Biology, pp. 515 - 536

Xue ML; Willcox MD; Lloyd AR; Wakefield D; Thakur A, 2001, 'Regulatory role of IL-IB in the expression of IL-6 and IL-8 in human corneal epithelial cells during Pseudomonas aeruginosa colonization', Clinical and Experimental Ophthalmology, pp. 171 - 174

Wilson A; Hickie IB; Hadzi-Pavlovic D; Wakefield D; Parker GB; Straus SE; Dale J; McCluskey D; Gwynneth H; Brickman A; Goldenberg D; Demitrack M; Blakely T; Wessely S; Sharp M; Lloyd AR, 2001, 'What is chronic fatigue syndome? Heterogeneity within an international multicentre study.', Australian and New Zealand Journal of Psychiatry, pp. 520 - 527

Harvey CE; Post JJ; Kumar RK; Freeman AJ; Lloyd AR; Marinos G, 2000, 'Interferon inducible protein 10 is expressed by hepatocytes in chronic hepatitis C virus infection and correlates with lobular inflammation.', HEPATOLOGY, 32, pp. 374A - 374A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000089622400847&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Freeman AJ; Dore GJ; Law MG; Thorpe M; Von Overbeck J; Lloyd AR; Marinos G; Kaldor JM, 2000, 'The natural history of chronic hepatitis C: A systematic review', HEPATOLOGY, 32, pp. 422A - 422A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000089622401038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cardillo R; Hassim Z; Tedla N; Lloyd AR; Grimm MC, 2000, 'VIP desensitizes chemokine receptors and impairs leukocyte trafficking and inflammation in vivo.', GASTROENTEROLOGY, 118, pp. A357 - A357, http://dx.doi.org/10.1016/S0016-5085(00)83531-3

Davenport MP; Grimm MC; Lloyd AR, 2000, 'A homing selection hypothesis for T-cell trafficking', Immunology Today, 21, pp. 315 - 317

Hickie IB; Wilson A; Wright MJ; Bennett BK; Wakefield D; Lloyd AROLA, 2000, 'A randomized, double-blind, placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome', Journal of Clinical Psychiatry, 61, pp. 643 - 648

Binotto E; Boughton CR; Hawkes R; Robertson PW; Whybin R; Duffy Y; Vollmer-Conna US; Lloyd AR, 2000, 'A serological and epidemiological re-evaluation of acute non-A non-B hepatitis from the early 1970's', Australian and New Zealand Journal of Psychiatry, pp. 668 - 674

Lloyd AR; Hickie IB; Loblay RH, 2000, 'Diagnostic criteria for chronic fatigue syndrome', Medical Journal of Australia, 172, pp. 472

Di Girolamo N; Mccluskey P; Lloyd AR; Coroneo MT; Wakefield D, 2000, 'Expression of MMPs and TIMPs in Human Pterygia and Cultured Pterygium Epithelial Cells', Investigative Ophthalmology and Visual Science, pp. 671 - 679

Freeman A; Zekry A; Whybin R; Harvey CE; Van Beek IA; De Kantzow SL; Rawlinson WD; Boughton CR; Robertson PW; Marinos G; Lloyd AR, 2000, 'Hepatitis C prevalence among Australian injecting drug users in the 1970s and profiles of virus genotypes in the 1970s and 1990s', Medical Journal of Australia, 172, pp. 588 - 591

Lloyd AR; Hickie IB; Loblay RH, 2000, 'Illness or disease? The case of chronic fatigue syndrome', Medical Journal of Australia, 172, pp. 471 - 472

Harrigan R; Storm PA; Lloyd AR; Arens ME; Marmion BP, 2000, 'Long-term persistence of coxiella burnetii in the host after primary Q fever', Epidemiology and Infection, 124, pp. 543 - 549

Hadzi-Pavlovic D; Hickie IB; Wilson A; Davenport T; Lloyd AR; Wakefield D, 2000, 'Screening for prolonged fatigue syndromes: validation of the SOFA scale', Social Psychiatry and Psychiatric Epidemiology, pp. 471 - 479

Koschera A; Hickie I; Hadzi-Pavlovic D; Wilson A; Lloyd A, 1999, 'Prolonged fatigue, anxiety and depression: exploring relationships in a primary care sample', Australian and New Zealand Journal of Psychiatry, 33, pp. 545 - 552, http://dx.doi.org/10.1046/j.1440-1614.1999.00593.x

Grimm MC; Hassim Z; Lloyd AR; Oppenheim JJ, 1999, 'Chemokine receptors are inhibited by vasoactive intestinal peptide: Desensitization of HIV-1 co-receptors', GASTROENTEROLOGY, 116, pp. A728 - A728, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000079778403161&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Palladinetti P; Wakefield D; Lloyd AR, 1999, 'Viral chemokine receptor US28 modulates the immune response to human cytomegalovirus.', FASEB JOURNAL, 13, pp. A658 - A658, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000082132900068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tedla NT; Palladinetti P; Wakefield D; Lloyd AR, 1999, 'Abundant expression of chemokines in malignant and infective human lymphadenopathies', Cytokine, 11, pp. 531 - 540

Back to profile page